APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
BTNL2 |
Q9UIR0
|
butyrophilin like 2
|
Enzyme modulator
|
8.6E-11 |
0.546 |
0.808 |
CCR2 |
P41597
|
C-C motif chemokine receptor 2
|
|
2.3E-02 |
0.418 |
0.846 |
CCR5 |
P51681
|
C-C motif chemokine receptor 5 (gene/pseudogene)
|
G-protein coupled receptor
|
4.3E-10 |
0.398 |
0.885 |
CD14 |
P08571
|
CD14 molecule
|
|
4.9E-05 |
0.392 |
0.885 |
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
CXCR3 |
P49682
|
C-X-C motif chemokine receptor 3
|
G-protein coupled receptor
|
0.18 |
0.436 |
0.808 |
DEFB1 |
P60022
|
defensin beta 1
|
|
0.41 |
0.509 |
0.808 |
FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
GEM |
P55040
|
GTP binding protein overexpressed in skeletal muscle
|
|
1.2E-08 |
0.467 |
0.769 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
HLA-C |
P10321
|
major histocompatibility complex, class I, C
|
|
1.6E-06 |
0.415 |
0.846 |
HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
IL12B |
P29460
|
interleukin 12B
|
Signaling
|
1.1E-04 |
0.480 |
0.885 |
IL13 |
P35225
|
interleukin 13
|
|
1.4E-02 |
0.386 |
0.846 |
IL15 |
P40933
|
interleukin 15
|
|
0.71 |
0.422 |
0.846 |
IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
IL17F |
Q96PD4
|
interleukin 17F
|
|
3.9E-02 |
0.480 |
0.808 |
IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |